US to Wind Down AIDS Funding in South Africa
US to phase out HIV/AIDS funding for South Africa, impacting prevention and treatment programs.
US to phase out HIV/AIDS funding for South Africa, impacting prevention and treatment programs.
Global health response to Ebola has improved since 2014-16, with better vaccines and coordination, but challenges remain.
China's capacity to respond to the Ebola outbreak in East Africa presents a strategic opportunity amid potential US withdrawal.
A new twice-yearly HIV prevention drug has arrived in Zambia, but concerns linger over the country's strained health system.
Emerging Hantavirus and Ebola cases highlight global health system vulnerabilities, demanding enhanced international cooperation and preparedness.
WHO declares Ebola outbreak in Congo and Uganda a Public Health Emergency of International Concern, advising against non-essential travel.
Ebola crisis sparks debate on global health double standards, with Africans citing unequal response and resource allocation.
Oxford University and Serum Institute of India partner on a new multi-stage malaria vaccine, R78C, aiming for broad accessibility.
Zambia's HIV/AIDS programs are crumbling due to U.S. funding cuts, reversing years of progress and threatening lives.
Analysis reveals high sodium and low fruit intake caused 5.91 million heart disease deaths in 2023, with China and India facing the highest absolute numbers.